5 research outputs found

    Lesions in the Posterior Visual Pathway Promote Trans-Synaptic Degeneration of Retinal Ganglion Cells

    No full text
    <div><p>Objective</p><p>Retrograde trans-synaptic degeneration of retinal ganglion cell layer (GCL) has been proposed as one of the mechanisms contributing to permanent disability after visual pathway damage. We set out to test this mechanism taking advantage of the new methods for imaging the macula with high resolution by optical coherence tomography (OCT) in patients with lesions in the posterior visual pathway. Additionally, we explored the association between thinning of GCL as an imaging marker of visual impairment such as visual field defects.</p><p>Methods</p><p>Retrospective case note review of patients with retrogeniculate lesions studied by spectral domain OCT of the macula and quadrant pattern deviation (PD) of the visual fields.</p><p>Results</p><p>We analysed 8 patients with either hemianopia or quadrantanopia due to brain lesions (stroke  = 5; surgery  = 2; infection  = 1). We found significant thinning of the GCL in the projecting sector of the retina mapping to the brain lesion. Second, we found strong correlation between the PD of the visual field quadrant and the corresponding macular GCL sector for the right (R = 0.792, p<0.001) and left eyes (R = 0.674, p<0.001).</p><p>Conclusions</p><p>The mapping between lesions in the posterior visual pathway and their projection in the macula GCL sector corroborates retrograde trans-synaptic neuronal degeneration after brain injury as a mechanism of damage with functional consequences. This finding supports the use of GCL thickness as an imaging marker of trans-synaptic degeneration in the visual pathway after brain lesions.</p></div

    Correlation coefficients between the GCL and RNFL thickness and the VF deviation in corresponding quadrants.

    No full text
    <p>Correlation coefficients between the GCL and RNFL thickness and the VF deviation in corresponding quadrants.</p

    Clinical features of patients with visual field defects secondary to retro-geniculate visual pathway lesions.

    No full text
    <p>Clinical features of patients with visual field defects secondary to retro-geniculate visual pathway lesions.</p
    corecore